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Abstract:
Macrophage (MΦ) activation must be tightly controlled to preclude overzealous responses that cause self-damage. MicroRNAs have been shown to promote classical MΦ activation by blocking anti-inflammatory signals and transcription factors, but can also prevent excessive TLR-signaling. In contrast, the microRNA profile associated with alternatively activated MΦ and their role in regulating wound-healing or anti-helminthic responses has not been described. Utilizing an in vivo model of alternative activation, in which adult Brugia malayi nematodes are surgically implanted in the peritoneal cavity of mice, we identified differential expression of miR-125b-5p, miR-146a-5p, miR-199b-5p and miR-378-3p in helminth induced MΦ. In vitro experiments demonstrated that miR-378-3p was specifically induced by IL-4 and revealed the IL-4-Receptor/PI3K/Aktsignaling pathway as a target. Chemical inhibition of this pathway showed that intact Akt-signaling is an important enhancement factor for alternative activation in vitro and in vivo and is essential for IL-4 driven MΦ proliferation in vivo. Thus our identification of miR-378-3p as an IL-4Rα-induced microRNA, led to the discovery that Akt regulates the newly discovered mechanisms of IL-4 driven macrophage proliferation. Together the data suggest that negative regulation of Akt-signaling via microRNAs might play a central role in limiting MΦ expansion and alternative activation during type 2 inflammatory settings.
Introduction
Macrophages (MΦ) are centrally involved in recognising and containing pathogens.
Subsequently they ensure the efficient induction and upkeep of a protective adaptive immune response. MΦ also help to limit the ensuing immune reaction as well as clear apoptotic cells and other debris. 1 The adaption of MΦ to these diverse roles is reflected in the multitude of activation phenotypes that have been described. 2 Classical (or M1-) and IL-4Rα-driven alternative (or M2-) activation represent the two most divergent phenotypes with the former thought to be proinflammatory and important for the clearance of microbial pathogens, whereas the latter are predominantly found during helminth-infections and are associated with wound-healing and immuno-suppression. [3] [4] [5] [6] In either case, MΦ-activation must be tightly controlled, as excessive activation can lead to tissue destruction or fibrosis, respectively. 6, 7 Control is achieved by external signals including cytokines (e.g. Interleukin (IL)-10, IL-27 8, 9 ) and hormones (e.g. glucocorticoids 10 ) but also by MΦ-intrinsic mechanisms. For example, classically activated MΦ become unresponsive to secondary stimulation with lipopolysaccharide (LPS) due, at least in part, to the induction of negative feedback loops blocking or limiting activating signaling cascades. 11 The possibility that microRNAs may mediate such feedback-mechanisms, has recently attracted considerable interest. 11 MicroRNAs (miRNA) are short (18-24nt) , non-coding RNAs that influence the translation of specific genes by binding to the 3' untranslated region (3'UTR) of the target messenger RNAs (mRNAs). The interaction between a miRNA and mRNA generally results in destabilization of the mRNA and repression of translation. 12 In MΦ miRNAs have so far been mainly studied during classical activation where a number of personal use only.
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miR-125b-5p is initially downregulated by LPS/TNF-induced Akt-signaling to allow efficient TNF-production, 14, 15 but is induced during later stages where it acts to limit further TNF-production. 16 Similarly miR-146a-5p is upregulated upon LPS-stimulation and targets the MAPK-signaling pathway of TLRs, specifically IRAK1 and TRAF6. 17 Thus, these miRNAs are part of feedback-loops that prevent excessive MΦ activation and limit potentially harmful proinflammatory responses. Another M1-associated miRNA, miR-155, can suppress M2 activation by targeting the IL-13 receptor 18 suggesting that miRNAs are also involved in shaping the M1/M2 balance. Furthermore, miRNAs have been shown to control cellular proliferation, 19 which has potential relevance to M2 MΦ activation due to the recent discovery that MΦ-expansion can occur by IL-4-driven local proliferation rather than recruitment from the blood. 20 However, the miRNA-profile associated with alternative activation of MΦ has yet to be described. We therefore aimed to identify miRNAs differentially expressed in an in vivo model of alternative activation and dissect their functional roles. Microarray-analysis of MΦ elicited by exposure to the nematode Brugia malayi 5 
Materials and Methods

Mice and Infection
Wild-type (WT, BALB/c or C57BL/6) and IL-4 Receptor-alpha deficient (IL-4Rα-/-) mice on a BALB/c background were bred in house. Mice were 6-10 weeks old at the start of each experiment and all work was performed in accordance with the UK Animals (Scientific Procedures) Act of 1986. Adult B. malayi parasites were isolated from the peritoneal cavity of infected Jirds purchased from TRS Laboratories or maintained in house. Infections were carried out as described previously. 21 A detailed description and additional information can be found in the supplementary material available online.
MΦ-isolation and purification
PEC were seeded at 5x10^6 cells per well to 6-well cell-culture plates (NUNC) in RPMI, 5% FCS, 2 mM L-glutamine, 0.25 U/mL penicillin and 100 mg/mL streptomycin. After 4 hours incubation at 37 °C / 5% CO 2 non-adherent cells were washed off and the adherent cells detached using a rubber-policeman. Detached cells were > 80% pure MΦ as assessed by flow-cytometry (FACS) analysis of their F4/80 and CD11b surface expression. In some experiments as indicated peritoneal MΦ were purified using FACSsorting on a FACSAria cell sorter (BD Biosciences) according to their expression of surface molecules (F4/80+, SiglecF-, CD11b+, CD11c-, B220-, CD3-; all antibodies purchased from BioLegend or eBioscience) reaching purities of above 90%. 
Cell-culture experiments
For in vitro experiments thioglycollate-elicited PEC were seeded to 24-well plates at 1x10^6 cells per well in complete RPMI. After 4 hours incubation, non-adherent cells were washed off and murine recombinant IL-4 (rIL-4, 20ng/mL, Peprotech), recombinant macrophage colony stimulating factor (rM-CSF, 20ng/ml, Peprotech), LPS (100ng/mL; Escherichia coli 0111:B4; Sigma-Aldrich) and recombinant Interferon-γ (rIFNγ, 20ng/mL, Peprotech) or medium alone were added and incubated for various periods of time as indicated in the text. For triciribine (1,5-dihydro-5-methyl-1-β-D-ribofuranosyl-1,2,5,6,8-pentaazaacenaphthylen-3-amine; Cayman Europe) treatment, cells were pretreated for 1 hour (see text for concentrations) prior to stimulation. Subsequently nonadherent cells were washed off and the remaining cells lysed in 700 μL Qiazol.
miRNA MicroArray
The miRCury miRNA probe set version 8.1 (Exiqon) was printed onto Codelink slides (GE Healthcare) in triplicate per array. Arrays were spot-checked using random hexamerlabelled RNAs. For experiments in this report, RNA (1 μg) was labelled using the Hy3 power labelling kit (Exiqon) and hybridization and washing were carried out following the manufacturer's instructions.
Array analysis was carried out using a comparative strategy in order to identify robustly regulated miRNAs. The background subtracted data were quantile normalized and the probes recognizing murine miRNA were selected to minimize the multiple testing problem. Medians were calculated for each miRNA per group (n = 4) and expression compared by t-test (WT v IL-4Rα-/-and WT v Thio). The regulated miRNA in each personal use only.
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Similarly to our analysis of medians we selected miRNAs as regulated if two or more probes for the miRNA had significant uncorrected p-values and the median was greater than the 50 th percentile. The lists from each analysis were then examined and overlapping miRNAs chosen for follow-up analysis. Microarray data have been deposited to NCBI's Gene Expression Omnibus and are accessible through GEO Series accession number GSE35047. SAS Institute Inc.). Differences between groups were determined by ANOVA followed by a Tukey-Kramer HSD multiple comparison-test. In some cases data was logtransformed to achieve normal distribution as determined by optical examination of personal use only. 
Dual-Luciferase Reporter Assay
Results
To identify miRNAs differentially regulated in alternatively activated MΦ in vivo we performed a miRNA array screen on peritoneal MΦ isolated from mice surgically implanted with the parasitic nematode B. malayi. As described previously, B. malayi implant results in a very strongly Th2-biased immune response and induces the accumulation of alternatively activated MΦ at the site of implantation. 5 For comparison, we used IL-4Rα-deficient (IL-4Rα -/-) animals whose MΦ fail to express alternative activation markers in this model. 25 Additional wildtype (WT) mice underwent sham surgery and were injected with thioglycollate 3 days prior to necropsy in order to generate inflammatory MΦ not associated with helminth infection. A two-way comparison of WT nematode elicited MΦ (NeMΦ) with thioglycollate-elicited MΦ (Thio-MΦ) or IL-4Rα -/-NeMΦ allowed us to identify infection-dependent and IL-4Rαdependent miRNAs respectively. Three weeks post implant MΦ were isolated from the peritoneal cavity by adherence to cell-culture plates and total RNA extracted as described in materials and methods. The expression levels of 648 unique human and mouse miRNAs in their mature form were determined using the Exiqon miRCury 8.1 array platform. Bioinformatic analysis (see Materials and Methods for details) revealed differential expression of 19 miRNAs in WT-NeMΦ compared to either Thio-MΦ or IL-
We then chose to validate expression levels of the 10 most differentially regulated miRNAs (i.e. highest fold change) identified in the array. A proportion of the originally isolated RNA was subjected to quantitative RT-PCR (qRT-PCR), with further analysis in two subsequent experiments using FACS-sorted MΦ (>90% F4/80+CD11b+). These personal use only.
For at ROYAL SCHOOL OF VETERINARY STUDIES on August 24, 2012. bloodjournal.hematologylibrary.org From experiments confirmed significant differential expression of 9 of these 10 miRNAs, but also revealed that only four of these were differentially regulated in both comparisons (WT NeMΦ versus WT Thio-MΦ and versus IL-4Rα -/-NeMΦ) and therefore specific for alternatively activated MΦ (Table 1 & Figure 1A ). miR-125b-5p, miR-199b-5p and miR-378-3p, were found to be significantly up-regulated in vivo whereas miR-146a-5p showed a tendency towards an IL-4Rα-dependent downmodulation ( Figure 1A ). This tendency in miR-146a-5p expression was statistically significant (P=.0022) when all three experiments were combined. To confirm the activation state of the isolated MΦ, expression of the alternative activation marker chitinase 3-like 3 (Chi3l3/Ym1) was measured and, as expected, found to be exclusively upregulated in WT NeMΦ but not in IL-4Rα -/-MΦ ( Figure 1B) .
It was possible that the changes we observed were the result of secondary (IL-4Rαdependent) events occurring in vivo and not due to direct MΦ activation via IL-4/13. Thus, we tested the expression of miR125b-5p, miR-146a-5p, miR-199b-5p and miR-378-3p in Thio-MΦ stimulated in vitro with rIL-4 or LPS and rIFNγ ( Figure 1C ).
Quantitative RT-PCR revealed significant upregulation of miR-125b-5p and miR-378-3p upon IL-4 treatment but not upon LPS/IFNγ-stimulation confirming the association of these miRNAs with the alternative activation phenotype. In contrast miR-199b-5p was not altered either by IL-4 or LPS/IFNγ treatment indicating that the observed upregulation in vivo is not due to direct effects of IL-4R-signaling on MΦ. miR-146a-5p has previously been found to be highly upregulated in classically activated MΦ 17 and was consequently specifically induced upon LPS/IFNγ stimulation but no change in expression could be detected upon IL-4-stimulation in vitro at this time point ( Figure 1C ). Successful and specific induction of alternative activation under these conditions was confirmed by Chi3l3-expression ( Figure 1D ). miR-125b-expression in MΦ has previously been demonstrated to be modulated by factors other than IL-4. 15, 16 We selected miR-378-3p for further investigation into its potential to regulate alternative activation of MΦ because it appeared to be the most specific for IL-4Rα-mediated signals. Further, miR-378-3p was of particular interest because it is encoded in an intronic region of the peroxisome proliferative activated receptor, gamma, coactivator 1 beta gene (Ppargc1b), 26 which has previously been shown to be associated with the alternative activation phenotype. 27 To evaluate whether upregulation of miR-378-3p was a prerequisite for alternative MΦ activation or a consequence thereof, we performed in vitro timecourse experiments of IL- and miR-146a-5p as described previously. 17, 28 Interestingly, in line with our in vivo data ( Figure 1A) , miR-146a-5p was significantly reduced following IL-4-stimulation at very late timepoints (45 hours) but not at 24 hours. This might explain why we were unable to personal use only.
For at ROYAL SCHOOL OF VETERINARY STUDIES on August 24, 2012. bloodjournal.hematologylibrary.org From detect a direct effect of IL-4 on miR-146a-5p expression in the previous in vitro experiments measured at 16 hours post treatment ( Figure 1C ). In order to examine cellular genes that respond to changes in miR-378-3p expression, we used a murine fibroblast cell line that expresses miR-378-3p and supports miRNA overexpression and inhibition analysis, as described. 29 NIH-3T3-fibroblasts were transfected with either miR-378-3p-mimics or -inhibitors and resulting changes in gene-expression analysed utilizing an Affymetrix-mRNA-array. We were able to identify 491 significantly differentially expressed genes (FDR P< .05) with more than 1.4 fold change in either of the two conditions as compared to a negative-control (RISC-free). Pathway analysis of these differentially expressed genes using DAVID Bioinformatics Resources for gene annotation and KEGG pathway analysis (http://david.abcc.ncifcrf.gov/tools.jsp) revealed the Jak-STAT signaling pathway as significantly targeted (EASE-score P< .05). More specifically in conjunction with the online prediction software Targetscan (TargetScanMouse; Release 5.1:April2009; www.targetscan.org) several potential targetgenes within the IL-4Rα/PI3K/Akt-signaling cascade could be identified. Figure 3A illustrates the components of the IL-4Rα pathway that were predicted by target scan (yellow) and differentially expressed in transfected fibroblasts (red). In particular Akt-1 was identified in both analyses. This suggested the possibility that IL-4 induction of miR-378-3p results in a negative feedback on the IL-4 signaling pathway. Because receptor 'tolerance' has not previously been described for this pathway, we tested whether IL-4 does induce a negative feedback-mechanism by measuring STAT-6-phosphorylation in Thio-MΦ following secondary IL-4 stimulation. As outlined in Figure 3B , MΦ that had personal use only.
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To obtain direct evidence that miR-378-3p targets the PI3k/Akt1-pathway we generated Luciferase-constructs containing the 3'UTR of thymoma viral proto-oncogene 1 (Akt1) or a mutated version thereof, where two nucleotides within both seed-region-binding sites for miR-378-3p were altered (Suppl. Figure 1A) . As shown in Figure 3C , co-transfecting NIH-3T3-fibroblasts with a mimic of miR-378-3p significantly inhibited Luciferase expression as compared to cells transfected with the Luciferase-construct alone, or cotransfected with a negative control RNA. Importantly these effects were lost when both miR-378-3p-binding sites within the Akt1 -3'UTR were mutated. Furthermore transfection of RAW264.7 cells led to a marked decrease in Akt-1 protein levels as assessed by Western Blot analysis (P< .01 in every comparison) ( Figure 3D&E ). Similar results were obtained for growth factor receptor bound protein 2 (Grb2), (P< .05) (Suppl. Figure 1B-D) . Interestingly use of a miR-378-3p inhibitor increased proteinexpression of Akt-1 in some experiments, but this was not significant when the data of several experiments was combined ( Figure 2D&E ).
The identification of Akt as a target of miR-378-3p led us to assess the potential influence of Akt-inhibition on MΦ alternative activation using a specific Akt-inhibitor (triciribine 30 ) ( Figure 4 ). Preincubation of Thio-MΦ with triciribine severely disrupted their ability to fully alternatively activate in a dose-dependent manner as shown for the expression of Chi3l3, resistin like alpha (Retnla/Relm-α) and arginase 1 (Arg1) ( Figure   4 ). Of note, Akt-inhibition differentially affected expression of these markers with complete abrogation of IL-4 driven Retnla-but only partial inhibition of Chi3l3-and personal use only. We recently demonstrated that proliferation of the local MΦ population is an integral part of Th2 mediated inflammation with no requirement for blood monocyte recruitment. 20 The expansion in cell numbers following surgical implantation of B. malayi nematodes occurs as an early burst of rapid cellular proliferation which then subsides. 20 Simultaneously protein levels of the alternative activation marker Relm-α was only partially reduced and YM-1 expression did not seem affected at all. These data indicate that similar to the effects observed in vitro, IL-4 induced Akt-signaling is responsible for only specific features of alternative MΦ activation, but is essential for IL-4 driven proliferation.
Furthermore to establish a role for miR-378-3p in the regulation of MΦ proliferation we transfected RAW264.7 cells with a miR-378-3p mimic or -inhibitor and analysed the resulting changes in cellular expansion. Conversion of alamarBlue® and loss of Vybrant®CFDA SE staining were used to monitor cell expansion and cell division, respectively. Over a 24 hr period, cells transfected with the miR-378-3p mimic displayed a significantly reduced increase in the conversion of alamarBlue® ( Figure 6B ) and loss of Vybrant®CFDA SE staining ( Figure 6C ) demonstrating that miR378-3p negatively regulated cell proliferation. Transfection with the miR-378-3p inhibitor had no effect on cellular expansion indicating that only enhanced miR-378-3p expression as found after IL-4 stimulation regulates proliferation. What is more, gene-expression analyses of RAW264.7 cells transfected with miR-378-3p showed significant reduction in expression of Akt-1 and Grb2, as well as the putative target Pik3cb ( Figure 3A ) and the proliferation marker Mki67 (Figure 6D ). Taken together these results are consistent with a negative Figure 7B ). Of note, IL-4c has previously been shown to also induce proliferation of CD8+ lymphocytes 31 as confirmed in our data by increased expression of cyclin A2 (Ccna2). The failure to induce miR-378-3p in these cells as well as in M-CSF stimulated macrophages indicates, that miR-378-3p is not a general feature of cellular proliferation whether IL-4 dependent or independent. Furthermore, the lack of induction of miR-378-3p in other cells stimulated with IL-4c shows, that although IL-4 signaling has widespread effects on various cell-types, the mechanisms controlling these effects are governed by different regulatory mechanisms. Induction of miR-378-3p therefore appears to be a very specific feature of alternative MΦ activation. 
Discussion
MΦ isolated from mice infected with the human filarial parasite B.malayi become alternatively activated due to exposure to Th2 cells. 21 In this in vivo setting, we have identified changes in MΦ expression of miR-125b-5p, miR-199b-5p, miR-378-3p and miR-146a-5p associated with IL-4Rα-driven alternative activation. In vitro confirmation revealed that miR-125b-5p, miR-378-3p and miR-146a-5p were directly regulated by IL-4 whereas miR-199b-5p was not, suggesting miR-199b-5p is induced in vivo by other factors and/or that IL-4 is not sufficient. Interestingly another miRNA, miR-223-3p, has recently been described to be associated with the alternative activation phenotype. 32 Indeed, miR-223-3p was significantly enhanced in WT NeMΦ vs. IL-4Rα-/-NeMΦ in our array but was not among the most highly differentially expressed microRNAs in this in vivo setting and thus not pursued in this study.
Both miR-125b-5p and miR-146a-5p have already been associated with classical MΦ activation. miR-125b-5p expression is initially reduced following LPS-stimulation allowing efficient production of its target, the proinflammatory cytokine TNF-α 15 but miR-125b-5p is then upregulated during LPS-tolerance to prevent further/excessive TNFproduction. 16 Thus, miR-125b-5p upregulation in alternatively activated MΦ may represent a failsafe-switch preventing concomitant production of proinflammatory mediators like TNF-α. miR-146a-5p on the other hand is normally induced following classical activation of monocytes and is presumed to act in a feedback loop blocking further TLR-and cytokine-signaling. 17,33 Down-modulation of this miRNA in IL-4 stimulated MΦ could enhance TLR-signaling and thus seems counterintuitive. However, personal use only.
For at ROYAL SCHOOL OF VETERINARY STUDIES on August 24, 2012. bloodjournal.hematologylibrary.org From 1 reduced levels of miR-146a-5p did not occur until very late following IL-4 stimulation ( Figure 3 ) and longterm pre-incubation of MΦ with IL-4 has previously been shown to potentiate production of proinflammatory cytokines following secondary stimulation with LPS. 34 Thus, whereas upregulation of miR-125b-5p might help prevent concomitant production of inflammatory mediators, miR-146a-5p-downmodulation may simultaneously sensitise MΦ for potential bacterial pathogens and allow MΦ to quickly adapt their activation phenotype to newly arising challenges. Further experiments are needed to determine the exact role of these two miRNAs in shaping MΦ activation.
Here we focus on the new finding that upregulation of miR-378-3p is part of the alternative MΦ activation programme. This is consistent with a report that miR-378-3p is upregulated in a model of allergic airway inflammation. 35 Although the authors did not perform cell-type specific analyses, the inflammatory response in these models is characterised by the accumulation of MΦ exhibiting an alternative activation phenotype. 36 As noted above, miR-378-3p is encoded in an intronic region of Ppargc1b, 26 a protein associated with alternative activation. 27 Thus coexpression of miR-378-3p may have evolved to complement the role of the protein-encoding gene. 37 Ppargc1b is expressed by 4 hours following IL-4 stimulation and this would suggest that Ppargc1b and the primary transcript of mir-378-3p, are primary targets of IL-4 induced gene transcription. However, the mature form of miR-378-3p is delayed with respect to its parent gene and other alternative activation markers and thus secondary factors may be needed to regulate its processing.
We identified several miR-378-3p targets within the IL-4R-signaling cascade and more specifically within the PI3K/Akt-signaling pathway. Previous work by MacKinnon et al 38 personal use only.
For at ROYAL SCHOOL OF VETERINARY STUDIES on August 24, 2012. bloodjournal.hematologylibrary.org From showed that signaling via PI3K is important for full alternative activation of MΦ and we have extended these findings by using the Akt-specific inhibitor triciribine confirming Akt as an important downstream target of PI3K during IL-4 induced alternative activation. Interestingly Varin et al 39 showed that pre-treatment of MΦ with IL-4 prevented subsequent Akt-signaling induced by Neisseria meningitidis suggesting the induction of a feedback inhibitory mechanism by IL-4. Importantly these effects were not observed until approximately 12 hours post IL-4 stimulation, a timepoint which roughly coincides with the induction of miR-378-3p in our experiments. In addition miR-378-3p has been predicted to target the progesterone-receptor 40 and progesterone has been shown to be an important enhancement factor for alternative activation in wound healing. 41 Taken together these findings strongly suggest a role for miR-378-3p as feedback inhibitor of alternative activation. In this context PI3K/Akt signaling has been shown to enhance anti-inflammatory cytokine production during classical MΦ activation and simultaneously reduce production of pro-inflammatory cytokines. 42 Thus, induction of miR-378-3p and limitation of Akt-signaling in alternatively activated MΦ could, similar to our findings with miR-146a-3p, indicate a sensitisation for potential concomitant bacterial infections. PI3K/Akt is a central signaling pathway important for cellular growth and survival, triggered by various growth factors and insulin, but also by cytokines and TLRstimulation. 43 Although tissue MΦ have been typically regarded as non-dividing, recent data shows that resident MΦ numbers can be maintained by proliferation. 20, 44, 45 We further demonstrated that tissue MΦ can undergo rapid and extensive proliferation in vivo in response to IL-4 as a mechanism of Th2-driven inflammation that can replace personal use only.
For at ROYAL SCHOOL OF VETERINARY STUDIES on August 24, 2012. bloodjournal.hematologylibrary.org From monocyte recruitment. 20 Using triciribine we show here that, similar to the findings in vitro, intact PI3K/Akt-signaling enhances alternative activation of MΦ in vivo but moreover is absolutely essential for IL-4 induced MΦ proliferation. In a related context miR-378-3p has been shown to be upregulated during differentiation of proliferating myoblasts to non-proliferating myotubes and consequently severely downmodulated in cardiotoxin induced muscle-regeneration. 46 Similarly in a model of surgically induced liver injury downmodulation of miR-378-3p has been proposed to allow efficient hepatocyte proliferation by derepressing pro-proliferative molecules like ornithine decarboxylase. 47 A human ortholog of miR-378-3p with identical mature sequence, miR-422a, has, in concert with other miRNAs, been proposed to block proliferation of tumor cells by targeting the MAPK pathway. 48 Taken together with our observation that miR-378-3p negatively regulated RAW264.7 cell-expansion, these results suggest that miR-378-3p is centrally involved in the control of proliferation. Indeed some of the main pathways identified as potential targets for miR-378-3p in our bioinformatic pathway analysis of transfected fibroblasts, in addition to the Jak/Stat-signaling pathway, included cell cycle, p53-and MAPK signaling pathways, which merit further validation.
Importantly our data indicates, that despite miR-378-3p having the potential to control proliferation in various cell-types and under multiple settings, its induction under normal conditions seems restricted to IL-4 activated MΦ. Most likely this reflects the fact that miR-378-3p will target other, as yet undefined target genes besides Akt1 and thus have a much broader effect on the cellular phenotype, than discussed here.
We have been unable to demonstrate significant MΦ proliferation with IL-4 in vitro suggesting that additional signals to the cell, either through cell-cell contacts, or as yet personal use only.
For at ROYAL SCHOOL OF VETERINARY STUDIES on August 24, 2012. bloodjournal.hematologylibrary.org From undefined soluble mediators are required. Additionally, miRNAs do not typically induce complete knockdown of their targets, 12 and miRNAs often act in families targeting a whole metabolic or signaling pathway rather than individual members of these pathways leading to a general suppression of whole metabolic or activation programmes. 49 Beyond the putative link between miR-378-3p and IL-4 driven macrophage proliferation, this study has generated the novel and important finding that miR-378-3p is an IL-4dependent miRNA upregulated in MΦ, both in vitro and in vivo which targets the Aktsignaling pathway. Importantly, this finding has led to the independent observation that the local MΦ proliferation that occurs during Th2 mediated inflammation relies on Akt.
This has important therapeutic implications as PI3K/Akt inhibitors are already being developed to target proliferation during cancer 50,51 and thus might have off target effects on MΦ. Additionally, efforts to target this pathway may generate important therapeutics to control MΦ proliferation, which is believed to exacerbate diseases such as glomerulonephritis and atherosclerosis. 52, 53 personal use only. 
